Surgical Versus Nonsurgical Management of Pancreatic Neuroendocrine Tumors: A Systematic Review and Meta-Analysis

  • 0Department of General, Visceral and Transplantation Surgery, Heidelberg University, Heidelberg, Germany.

|

|

Summary

This summary is machine-generated.

Surgical management of pancreatic neuroendocrine tumors (PNETs) significantly improves overall survival compared to nonsurgical approaches. However, for very small, asymptomatic PNETs, nonsurgical options may be considered.

Area Of Science

  • Oncology
  • Surgical Oncology
  • Gastroenterology

Background

  • Pancreatic neuroendocrine tumors (PNETs) are rare cancers.
  • Surgical resection is a primary treatment, but its optimal role is debated.

Purpose Of The Study

  • To compare the effectiveness of surgical versus nonsurgical management for PNETs.
  • To analyze survival outcomes in patients with PNETs undergoing different treatment modalities.

Main Methods

  • Systematic literature search of Medline, Scopus, Web of Science, and Embase databases.
  • Meta-analysis of 77 studies including 62,654 patients comparing surgical and nonsurgical PNET management.
  • Primary endpoint was overall survival; subgroup analyses included tumor grade, size, and functional status.

Main Results

  • Surgical management was associated with a significantly lower mortality risk (HR 0.30, P < 0.001).
  • Improved 1-, 3-, 5-, and 10-year survival rates were observed in surgically treated patients.
  • Surgical intervention showed survival benefits across various PNET subtypes, except for PNETs < 1 cm.

Conclusions

  • Surgical management offers superior outcomes for resectable PNETs and should be the primary consideration.
  • Nonsurgical management is a viable option for select patients with small (<1 cm), asymptomatic PNETs.